Low-dose CBD enhanced THC intoxication while high-dose CBD reduced it, especially in infrequent users | Research

The takeaway

In a randomized controlled trial of vaporized cannabinoids, low-dose CBD (4 mg) enhanced THC intoxication while high-dose CBD (400 mg) reduced it, with infrequent cannabis users most affected by the enhancing effect.

Cannabis consumers, product developers, medical cannabis prescribers, and regulators setting THC:CBD ratio guidelines.

Low CBD enhanced intoxication; high CBD reduced it (p < .0001)

What the researchers found

CBD alone (400 mg) showed some intoxicating properties vs. placebo. When combined with 8 mg THC, low CBD (4 mg) enhanced intoxication while high CBD (400 mg) reduced it. The enhancement by low-dose CBD was especially prominent in infrequent cannabis users and consistent across objective and subjective measures. Most effects were significant at p < .0001.

Why it matters

This fundamentally challenges the simple narrative that "CBD counteracts THC." The dose matters enormously, and low-dose CBD (the ratio found in many commercial products) may actually make THC more intoxicating.

The numbers in context

36 participants. 5 conditions. CBD alone (400 mg) was somewhat intoxicating. Low CBD (4 mg) + THC (8 mg) enhanced intoxication. High CBD (400 mg) + THC (8 mg) reduced intoxication. Effects significant at p < .0001.

How the study worked

Randomized, placebo-controlled trial with 36 participants (31 male) completing 5 drug conditions one week apart: placebo, CBD alone (400 mg), THC alone (8 mg), THC + low CBD (4 mg), THC + high CBD (400 mg). Administered by vaporization.

What this study cannot tell us

Relatively small sample (n=36). Predominantly male (31/36). Vaporization delivery may not generalize to other routes. Only two CBD doses tested, so the threshold for switching from enhancement to reduction is unknown.

How to read the evidence

Strong: randomized, placebo-controlled, within-subjects design with multiple conditions and objective/subjective measures.

When this study was published

Published in 2019.

The bigger picture

Many cannabis products contain low CBD-to-THC ratios. This study suggests these products may be more intoxicating than THC alone, the opposite of what consumers expect. The vulnerability of infrequent users is particularly concerning.

Questions still open

At what CBD dose does the effect switch from enhancement to reduction? Should product labels warn about low-dose CBD enhancement? Are commercial cannabis products inadvertently maximizing intoxication through low CBD content?

Common questions

Does CBD always reduce THC effects?

No. This study found that only high-dose CBD (400 mg) reduced THC intoxication. Low-dose CBD (4 mg) actually enhanced it. The commonly repeated claim that CBD counteracts THC is oversimplified.

Why were infrequent users more affected?

Infrequent users may have less tolerance and more sensitive cannabinoid systems, making them more susceptible to the enhancing effect of low-dose CBD on THC intoxication.

Read the original research

A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.

European archives of psychiatry and clinical neuroscience, 269(1), 17-35

View on PubMed ↗Publisher’s paper ↗

Citation

Solowij, Nadia; Broyd, Samantha; Greenwood, Lisa-Marie; van Hell, Hendrika; Martelozzo, Dave; Rueb, Kuna; Todd, Juanita; Liu, Zheng; Galettis, Peter; Martin, Jennifer; Murray, Robin; Jones, Alison; Michie, Patricia T; Croft, Rodney. (2019). A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.. European archives of psychiatry and clinical neuroscience, 269(1), 17-35. https://doi.org/10.1007/s00406-019-00978-2